Skip to content

Rapid One Step Buprenorphine Test Card

by Tianjin New Bay Bioresearch Co., Ltd.

510(k) K042988

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK042988 Date12 May 2005ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DJG
Device Class
Class II
Regulation
21 CFR Part 862.3650
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an enzyme immunoassay for opiates, specifically designed for the detection of buprenorphine. It is a rapid one-step test card format intended for qualitative screening.

The test card is supplied for use in clinical toxicology settings and has received FDA 510(k) clearance under K042988. It is classified as a Class II medical device with product code DJG and regulation number 862.3650.

Other devices from Tianjin New Bay Bioresearch Co., Ltd.

See all devices from Tianjin New Bay Bioresearch Co., Ltd. →